Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03018730
Brief Title: Safety and Efficacy of PRX 102 in Patients With Fabry Disease Currently Treated With REPLAGAL® (Agalsidase Alfa)

First Submitted : January 9, 2017
First Submitted that Met QC Criteria : January 10, 2017
First Posted : January 12, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : January 4, 2021
Last Update Posted : January 5, 2021